institutionid,scoredate,scoretype,aspectname,scorevalue,gvkey,ticker,companyname
4623856,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EMS: Certification/ Audit/ Verification,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EP - Electricity Purchased,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Energy Use,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Materiality,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Hazardous Waste,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Low-Carbon Products,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,NOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,SOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sustainability Reporting Assurance,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Volatile Organic Compounds Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Waste Disposal,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Water Use,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Analysis of Risks,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Audit Conflict of Interest,99,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Effectiveness,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corporate Governance Policy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Critical Supplier Identification,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Customer Feedback Process,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Customer Satisfaction Measurement,39,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,ESG Integration in SCM Strategy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Open Innovation,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Opportunities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Product Innovations (Healthcare),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Development Stages,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Ideation or Applied Research,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Launch,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Post-Launch,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Responsibility Risk & Crisis Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Risk Response Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sales Channels Variety & Innovation,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sales Effectiveness Targets,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sensitivity Analysis & Stress Testing,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Service Orientation,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supplier Risk Management Measures,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supply Chain Risk Exposure,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Benefits Sharing,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Business and Human Rights,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,CEO Compensation - Success Metrics,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corporate Citizenship Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Employee Turnover Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Fair Pricing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Fatalities,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Health Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Human Capital Performance Indicators,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Measure Contribution to Health Outcome,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Percentage of Performance Related Compensation for each E,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Personal and Organizational Learning and Development,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Philanthropic Contributions,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Assurance,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Materiality,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Quantitative Data,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Governance,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Implementation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Review,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Trend of Employee Wellbeing,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Volume,23,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Workforce Breakdown: Gender,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Economic Governance Dimension,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Environmental Dimension,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Social Dimension,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Climate Strategy,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Environmental Policy & Management Systems,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Environmental Reporting,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Operational Eco-Efficiency,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Corporate Governance,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Customer Relationship Management,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Innovation Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Marketing Practices,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Risk & Crisis Management,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Supply Chain Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Access to Healthcare,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Addressing Cost Burden,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Bioethics,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Human Capital Development,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Labor Practice Indicators,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Occupational Health & Safety,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Social Reporting,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Stakeholder Engagement,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Talent Attraction & Retention,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,S&P Global ESG Score,S&P Global ESG Score,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EMS: Certification/ Audit/ Verification,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,EP - Electricity Purchased,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Energy Use,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Materiality,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Financial Opportunities Arising from Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Hazardous Waste,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Low-Carbon Products,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,NOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,SOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sustainability Reporting Assurance,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Volatile Organic Compounds Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Waste Disposal,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Water Use,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Analysis of Risks,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Audit Conflict of Interest,99,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Effectiveness,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,CEO-to-Employee Pay Ratio,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corporate Governance Policy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Critical Supplier Identification,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Customer Feedback Process,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Customer Satisfaction Measurement,39,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,ESG Integration in SCM Strategy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Open Innovation,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Opportunities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Product Innovations (Healthcare),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Development Stages,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Ideation or Applied Research,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Launch,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Post-Launch,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,R&D Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Responsibility Risk & Crisis Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Risk Response Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sales Channels Variety & Innovation,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sales Effectiveness Targets,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Sensitivity Analysis & Stress Testing,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Service Orientation,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supplier Risk Management Measures,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supply Chain Risk Exposure,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Balance of Variable Compensation Based on Corporate and I,,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Benefits Sharing,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Business and Human Rights,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,CEO Compensation - Success Metrics,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Contribution to Increasing Healthcare Efficiency,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Corporate Citizenship Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Coverage of Employees through Predefined Performance Appr,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Employee Turnover Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Fair Pricing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Fatalities,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Health Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Human Capital Performance Indicators,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Human Resource Skill Mapping and Developing Process,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Measure Contribution to Health Outcome,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Payout Type of Total Performance-Related Compensation,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Percentage of Performance Related Compensation for each E,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Personal and Organizational Learning and Development,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Philanthropic Contributions,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Assurance,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Materiality,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Social Reporting - Quantitative Data,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Governance,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Implementation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Stakeholder Engagement Review,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Trend of Employee Wellbeing,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Volume,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Question,Workforce Breakdown: Gender,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Economic Governance Dimension,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Environmental Dimension,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Dimension,Social Dimension,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Climate Strategy,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Environmental Policy & Management Systems,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Environmental Reporting,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Operational Eco-Efficiency,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Corporate Governance,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Customer Relationship Management,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Innovation Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Marketing Practices,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Risk & Crisis Management,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Supply Chain Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Access to Healthcare,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Addressing Cost Burden,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Bioethics,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Corporate Citizenship & Philanthropy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Human Capital Development,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Labor Practice Indicators,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Occupational Health & Safety,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Social Reporting,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Stakeholder Engagement,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2013-09-12,Criteria,Talent Attraction & Retention,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Chemical Oxygen Demand,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EP - Biological Oxygen Demand,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EP - Electricity Purchased,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Energy Use,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Materiality,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Hazardous Waste,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Low-Carbon Products,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,NOx Emissions,1,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,SOx Emissions,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Volatile Organic Compounds Emissions,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Waste Disposal,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Water Use,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Analysis of Risks,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Audit Conflict of Interest,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Diversity Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Compliance to Regulatory Standards,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corporate Governance Policy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Critical Supplier Identification,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Customer Feedback Process,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Customer Satisfaction Measurement,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,ESG Integration in SCM Strategy,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Open Innovation,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Opportunities,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Product Innovations (Healthcare),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Product Recalls (Health Care),10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Development Stages,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Ideation or Applied Research,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Launch,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Post-Launch,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Responsibility Risk & Crisis Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Risk Response Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sales Channels Variety & Innovation,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sales Effectiveness Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sensitivity Analysis & Stress Testing,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Service Orientation,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supplier Risk Management Measures,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Tax Reporting,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Taxation Governance & Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Accessibility & Transparency of Outcome Data,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Benefits Sharing,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Business and Human Rights,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,CEO Compensation - Success Metrics,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corporate Citizenship Strategy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Development Programs,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Fair Pricing,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Fatalities,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Gender Pay Indicators,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,HTA Support of Value Proposition,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Health Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Human Capital Performance Indicators,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Labor KPIs - Layoffs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Measure Contribution to Health Outcome,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Network Orientation,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Percentage of Performance Related Compensation for each E,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Philanthropic Contributions,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Public Commitment to Human Rights,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Materiality,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Quantitative Data,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Governance,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Implementation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Review,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Training & Development Inputs,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Trend of Employee Wellbeing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Volume,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Workforce Breakdown: Gender,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Economic Governance Dimension,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Environmental Dimension,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Social Dimension,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Climate Strategy,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Environmental Reporting,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Operational Eco-Efficiency,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Customer Relationship Management,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Innovation Management,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Marketing Practices,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Product Quality & Recall Management,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Risk & Crisis Management,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Supply Chain Management,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Tax Strategy,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Access to Healthcare,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Addressing Cost Burden,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Bioethics,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Health Outcome Contribution,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Human Capital Development,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Labor Practice Indicators,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Occupational Health & Safety,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Social Reporting,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Stakeholder Engagement,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Talent Attraction & Retention,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,S&P Global ESG Score,S&P Global ESG Score,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Chemical Oxygen Demand,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct Greenhouse Gas Emissions (Scope 1),20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EP - Biological Oxygen Demand,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,EP - Electricity Purchased,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Energy Use,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Materiality,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Hazardous Waste,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 2),35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Low-Carbon Products,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,NOx Emissions,1,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,SOx Emissions,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Volatile Organic Compounds Emissions,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Waste Disposal,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Water Use,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Analysis of Risks,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Audit Conflict of Interest,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Diversity Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,CEO-to-Employee Pay Ratio,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Compliance to Regulatory Standards,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corporate Governance Policy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Critical Supplier Identification,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Customer Feedback Process,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Customer Satisfaction Measurement,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,ESG Integration in SCM Strategy,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Open Innovation,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Opportunities,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Product Innovations (Healthcare),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Product Recalls (Health Care),10,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Development Stages,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Ideation or Applied Research,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Launch,,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Post-Launch,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,R&D Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Responsibility Risk & Crisis Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Risk Response Strategy,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sales Channels Variety & Innovation,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sales Effectiveness Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Sensitivity Analysis & Stress Testing,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Service Orientation,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supplier Risk Management Measures,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Tax Reporting,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Taxation Governance & Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Accessibility & Transparency of Outcome Data,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Balance of Variable Compensation Based on Corporate and I,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Benefits Sharing,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Business and Human Rights,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,CEO Compensation - Success Metrics,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Contribution to Increasing Healthcare Efficiency,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Corporate Citizenship Strategy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Coverage of Employees through Predefined Performance Appr,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Development Programs,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Fair Pricing,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Fatalities,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,HTA Support of Value Proposition,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Health Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Human Capital Performance Indicators,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Labor KPIs - Layoffs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Measure Contribution to Health Outcome,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Network Orientation,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Percentage of Performance Related Compensation for each E,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Philanthropic Contributions,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Public Commitment to Human Rights,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Materiality,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Social Reporting - Quantitative Data,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Governance,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Implementation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Stakeholder Engagement Review,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Training & Development Inputs,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Trend of Employee Wellbeing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Volume,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Question,Workforce Breakdown: Gender,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Economic Governance Dimension,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Environmental Dimension,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Dimension,Social Dimension,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Climate Strategy,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Environmental Reporting,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Operational Eco-Efficiency,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Customer Relationship Management,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Innovation Management,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Marketing Practices,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Product Quality & Recall Management,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Risk & Crisis Management,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Supply Chain Management,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Tax Strategy,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Access to Healthcare,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Addressing Cost Burden,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Bioethics,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Corporate Citizenship & Philanthropy,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Health Outcome Contribution,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Human Capital Development,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Labor Practice Indicators,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Occupational Health & Safety,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Social Reporting,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Stakeholder Engagement,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2014-09-11,Criteria,Talent Attraction & Retention,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Change Governance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Coverage of Environmental Management Policy,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EP - Electricity Purchased,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Energy Use,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Materiality,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Financial Risks of Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,NOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,SOx Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Volatile Organic Compounds Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Waste Disposal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Water Use,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Diversity Policy,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,CEO Compensation - Success Metrics,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Compliance to Regulatory Standards,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Critical Supplier Identification,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Customer Satisfaction Measurement,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,ESG Integration in SCM Strategy,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Emerging Risks,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Management Ownership Requirements,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Open Innovation,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Opportunities,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Product Recalls (Health Care),0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Quality Management & Audits of Distribution Networks,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Development Stages,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Ideation or Applied Research,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Launch,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Post-Launch,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Responsibilities and Committees,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risk Culture,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sales Channels Variety & Innovation,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sales Effectiveness Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Service Orientation,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supplier Risk Management Measures,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Taxation Governance & Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Accessibility & Transparency of Outcome Data,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Benefits Sharing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Business and Human Rights,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Corporate Citizenship Strategy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Development Programs,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Fair Pricing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Fatalities,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Freedom of Association,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Gender Pay Indicators,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Health Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Human Capital Performance Indicators,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Labor KPIs - Layoffs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Measure Contribution to Health Outcome,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Network Orientation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Philanthropic Contributions,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Public Commitment to Human Rights,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Materiality,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Quantitative Data,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Governance,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Implementation,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Review,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Training & Development Inputs,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Trend of Employee Wellbeing,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Volume,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Workforce Breakdown: Gender,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Economic Governance Dimension,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Environmental Dimension,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Social Dimension,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Climate Strategy,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Environmental Policy & Management Systems,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Environmental Reporting,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Operational Eco-Efficiency,13,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Corporate Governance,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Customer Relationship Management,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Innovation Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Marketing Practices,92,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Product Quality & Recall Management,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Risk & Crisis Management,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Supply Chain Management,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Tax Strategy,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Access to Healthcare,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Addressing Cost Burden,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Bioethics,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Health Outcome Contribution,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Human Capital Development,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Labor Practice Indicators,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Occupational Health & Safety,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Social Reporting,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Stakeholder Engagement,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Talent Attraction & Retention,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,S&P Global ESG Score,S&P Global ESG Score,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Change Governance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate Strategy Impacts,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Coverage of Environmental Management Policy,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct Greenhouse Gas Emissions (Scope 1),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,EP - Electricity Purchased,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Energy Use,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Materiality,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Financial Risks of Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 2),20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,NOx Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,SOx Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Volatile Organic Compounds Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Waste Disposal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Water Use,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Diversity Policy,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,CEO Compensation - Success Metrics,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct: Coverage,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Compliance to Regulatory Standards,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Critical Supplier Identification,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Customer Satisfaction Measurement,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,ESG Integration in SCM Strategy,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Emerging Risks,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Ethical Marketing - Complaints Tracking,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Management Ownership Requirements,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Open Innovation,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Opportunities,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Product Recalls (Health Care),0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Quality Management & Audits of Distribution Networks,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Development Stages,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Ideation or Applied Research,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Launch,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,R&D Post-Launch,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Responsibilities and Committees,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risk Culture,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sales Channels Variety & Innovation,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sales Effectiveness Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Sensitivity Analysis & Stress Testing (including Water an,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Service Orientation,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supplier Risk Management Measures,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Supply Chain Transparency & Reporting,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Taxation Governance & Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Access to Genetic Resources,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Access to Healthcare Programs (Products),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Accessibility & Transparency of Outcome Data,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Benefits Sharing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Bioethics Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Business and Human Rights,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Corporate Citizenship Strategy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Development Programs,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Support Programs,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Fair Pricing,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Fatalities,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Freedom of Association,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Health Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Human Capital Performance Indicators,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Labor KPIs - Layoffs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Measure Contribution to Health Outcome,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Measuring Benefits,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Network Orientation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Occupational Illness Frequency Rate (OIFR) - Employees,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Partnerships for Access to Healthcare,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Philanthropic Contributions,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Public Commitment to Human Rights,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Materiality,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Social Reporting - Quantitative Data,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Governance,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Implementation,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Stakeholder Engagement Review,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Training & Development Inputs,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Trend of Employee Wellbeing,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Volume,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Question,Workforce Breakdown: Gender,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Economic Governance Dimension,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Environmental Dimension,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Dimension,Social Dimension,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Climate Strategy,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Environmental Policy & Management Systems,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Environmental Reporting,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Operational Eco-Efficiency,13,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Business Ethics,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Corporate Governance,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Customer Relationship Management,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Innovation Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Marketing Practices,92,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Product Quality & Recall Management,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Risk & Crisis Management,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Supply Chain Management,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Tax Strategy,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Access to Healthcare,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Addressing Cost Burden,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Bioethics,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Corporate Citizenship & Philanthropy,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Health Outcome Contribution,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Human Capital Development,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Labor Practice Indicators,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Occupational Health & Safety,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Social Reporting,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Stakeholder Engagement,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2015-09-10,Criteria,Talent Attraction & Retention,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Strategy Impacts,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),92,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EP - Biological Oxygen Demand,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EP - Electricity Purchased,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Energy Use,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Volatile Organic Compounds Emissions,1,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Waste Disposal,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Water Use,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Diversity Policy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Effectiveness,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,CEO Compensation - Success Metrics,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct: Coverage,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Compliance to Regulatory Standards,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Critical Supplier Identification,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,ESG Integration in SCM Strategy,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Ethical Marketing - Complaints Tracking,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Management Ownership Requirements,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Material Issues for Enterprise Value Creation,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Open Innovation,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Opportunities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Product Recalls (Health Care),52,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Launch,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Post-Launch,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risk Culture,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Service Orientation,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supplier Risk Management Measures,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supply Chain Transparency & Reporting,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Taxation Governance & Risks,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Access to Medicine Strategy Reporting,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Corporate Citizenship Strategy,97,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Development Programs,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Support Programs,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Fatalities,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Freedom of Association,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Gender Pay Indicators,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Governance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Health Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Capital Performance Indicators,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Assessment,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Due Diligence Process,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Mitigation & Remediation,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Labor KPIs - Layoffs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Measure Contribution to Health Outcome,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Philanthropic Contributions,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Quantitative Data,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Training & Development Inputs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Trend of Employee Wellbeing,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Workforce Breakdown: Gender,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Economic Governance Dimension,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Environmental Dimension,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Social Dimension,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Climate Strategy,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Operational Eco-Efficiency,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Business Ethics,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Innovation Management,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Marketing Practices,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Materiality,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Product Quality & Recall Management,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Risk & Crisis Management,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Supply Chain Management,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Tax Strategy,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Access to Healthcare,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Health Outcome Contribution,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Human Capital Development,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Labor Practice Indicators,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Occupational Health & Safety,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Social Reporting,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Talent Attraction & Retention,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,S&P Global ESG Score,S&P Global ESG Score,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Change Governance,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate Strategy Impacts,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct Greenhouse Gas Emissions (Scope 1),92,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EP - Biological Oxygen Demand,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,EP - Electricity Purchased,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Energy Use,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 2),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Volatile Organic Compounds Emissions,1,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Waste Disposal,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Water Use,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Diversity Policy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Effectiveness,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,CEO Compensation - Success Metrics,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct: Coverage,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Compliance to Regulatory Standards,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Corruption & Bribery,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Critical Supplier Identification,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,ESG Integration in SCM Strategy,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Ethical Marketing - Complaints Tracking,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Initiatives Aimed at Ensuring Product Quality and Safety,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Management Ownership Requirements,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Material Issues for Enterprise Value Creation,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Non-Executive Chairperson/ Lead Director,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Open Innovation,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Opportunities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Process Innovations,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Product Recalls (Health Care),52,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Launch,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,R&D Post-Launch,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Responsibilities and Committees,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risk Culture,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Sensitivity Analysis & Stress Testing (including Water an,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Service Orientation,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supplier Risk Management Measures,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supply Chain Risk Exposure,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Supply Chain Transparency & Reporting,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Taxation Governance & Risks,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Transparency of Executive Compensation,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Access to Medicine Strategy Reporting,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Corporate Citizenship Strategy,97,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Development Programs,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Support Programs,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Employee Turnover Rate,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Fatalities,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Freedom of Association,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Governance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Health Management,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Healthy Lifestyle Incentive,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Capital Performance Indicators,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Assessment,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Due Diligence Process,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Human Rights Mitigation & Remediation,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Labor KPIs - Layoffs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Measure Contribution to Health Outcome,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Occupational Illness Frequency Rate (OIFR) - Employees,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Philanthropic Contributions,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Social Reporting - Quantitative Data,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Training & Development Inputs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Trend of Employee Wellbeing,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Question,Workforce Breakdown: Gender,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Economic Governance Dimension,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Environmental Dimension,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Dimension,Social Dimension,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Climate Strategy,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Operational Eco-Efficiency,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Business Ethics,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Innovation Management,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Marketing Practices,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Materiality,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Product Quality & Recall Management,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Risk & Crisis Management,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Supply Chain Management,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Tax Strategy,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Access to Healthcare,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Corporate Citizenship & Philanthropy,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Health Outcome Contribution,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Human Capital Development,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Labor Practice Indicators,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Occupational Health & Safety,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Social Reporting,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2016-09-08,Criteria,Talent Attraction & Retention,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Chemical Oxygen Demand,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate Strategy - CDP Alignment,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,EP - Biological Oxygen Demand,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Energy Consumption,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Volatile Organic Compounds Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Waste Disposal,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Water Consumption,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Anti-Competitive Practices,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Average Tenure,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Industry Experience,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Type,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,CEO Compensation - Success Metrics,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Compliance to Regulatory Standards,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Contributions & Other Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corruption & Bribery Cases,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Critical Supplier Identification,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,ESG Integration in SCM Strategy,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Ethical Marketing - Complaints Tracking,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Impact Valuation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Largest Contributions & Expenditures,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Management Ownership Requirements,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Material Issues for Enterprise Value Creation,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Materiality Analysis,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Product Recalls (Health Care),61,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Launch,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Responsibilities and Committees,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supplier Risk Management Measures,13,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supply Chain Risk Exposure,14,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supply Chain Transparency & Reporting,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Taxation Governance & Risks,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Valuation Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Access to Medicine Strategy Reporting,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Support Programs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Turnover Rate,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Gender Pay Indicators,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Governance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Healthy Lifestyle Incentive,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Assessment,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Commitment,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Mitigation & Remediation,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,5,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Philanthropic Contributions,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Quantitative Data,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Training & Development Inputs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Trend of Employee Wellbeing,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Workforce Breakdown: Gender,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Economic Governance Dimension,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Environmental Dimension,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Social Dimension,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Climate Strategy,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Operational Eco-Efficiency,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Business Ethics,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Corporate Governance,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Impact Measurement & Valuation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Innovation Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Marketing Practices,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Materiality,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Policy Influence,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Product Quality & Recall Management,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Risk & Crisis Management,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Supply Chain Management,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Tax Strategy,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Access to Healthcare,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Health Outcome Contribution,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Human Capital Development,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Human Rights,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Labor Practice Indicators,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Occupational Health & Safety,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Social Reporting,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Talent Attraction & Retention,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,S&P Global ESG Score,S&P Global ESG Score,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate Strategy - CDP Alignment,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Climate-Related Management Incentives,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,EMS: Certification/ Audit/ Verification,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,EP - Biological Oxygen Demand,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Emissions Reduction Targets,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Energy Consumption,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Reporting - Quantitative Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Indirect Greenhouse Gas Emissions (Scope 3),50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Volatile Organic Compounds Emissions,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Waste Disposal,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Water Consumption,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Anti-Competitive Practices,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Average Tenure,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Industry Experience,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Board Type,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,CEO Compensation - Success Metrics,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Compliance to Regulatory Standards,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Contributions & Other Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corruption & Bribery Cases,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Critical Supplier Identification,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing: OPDP,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Direct-to-Consumer Marketing: Policies,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,ESG Integration in SCM Strategy,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Ethical Marketing - Complaints Tracking,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Expenses Associated with Product Recalls,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Impact Valuation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Initiatives Aimed at Ensuring Product Quality and Safety,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Largest Contributions & Expenditures,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Management Ownership Requirements,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Material Issues for Enterprise Value Creation,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Materiality Analysis,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Product Recalls (Health Care),61,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Launch,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Responsibilities and Committees,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Risks Correlation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supplier Risk Management Measures,13,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supply Chain Risk Exposure,14,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Supply Chain Transparency & Reporting,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Taxation Governance & Risks,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Valuation Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Access to Medicine Strategy Reporting,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Support Programs,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Employee Turnover Rate,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Governance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Healthy Lifestyle Incentive,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Assessment,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Commitment,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Human Rights Mitigation & Remediation,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,5,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Network Orientation,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Philanthropic Contributions,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Social Reporting - Quantitative Data,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Training & Development Inputs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Trend of Employee Wellbeing,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Type of Philanthropic Activities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Question,Workforce Breakdown: Gender,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Economic Governance Dimension,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Environmental Dimension,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Dimension,Social Dimension,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Climate Strategy,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Environmental Policy & Management Systems,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Operational Eco-Efficiency,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Business Ethics,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Corporate Governance,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Impact Measurement & Valuation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Innovation Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Marketing Practices,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Materiality,87,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Policy Influence,86,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Product Quality & Recall Management,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Risk & Crisis Management,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Supply Chain Management,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Tax Strategy,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Access to Healthcare,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Corporate Citizenship & Philanthropy,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Health Outcome Contribution,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Human Capital Development,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Human Rights,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Labor Practice Indicators,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Occupational Health & Safety,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Social Reporting,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2017-09-07,Criteria,Talent Attraction & Retention,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate Strategy - CDP Alignment,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate-Related Management Incentives,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,EMS: Certification/ Audit/ Verification,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Energy Consumption,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Reporting - Quantitative Data,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),34,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Volatile Organic Compounds Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Anti-Competitive Practices,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Average Tenure,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Industry Experience,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Type,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Compliance to Regulatory Standards,93,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Contributions & Other Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corruption & Bribery Cases,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Critical Supplier Identification,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,ESG Integration in SCM Strategy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Family Ownership,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Largest Contributions & Expenditures,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Management Ownership,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Material Issues for Enterprise Value Creation,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Product Recalls (Health Care),59,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Launch,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Risk Culture,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supplier Risk Management Measures,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supply Chain Transparency & Reporting,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Access to Medicine Strategy Reporting,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Support Programs,93,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Turnover Rate,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Gender Pay Indicators,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Assessment,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Mitigation & Remediation,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Patent Filing Policy,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Philanthropic Contributions,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Coverage,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Quantitative Data,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Trend of Employee Wellbeing,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Workforce Breakdown: Gender,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Economic Governance Dimension,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Environmental Dimension,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Social Dimension,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Climate Strategy,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Environmental Policy & Management Systems,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Environmental Reporting,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Operational Eco-Efficiency,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Business Ethics,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Corporate Governance,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Innovation Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Materiality,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Policy Influence,91,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Product Quality & Recall Management,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Risk & Crisis Management,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Supply Chain Management,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Access to Healthcare,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Human Capital Development,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Human Rights,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Labor Practice Indicators,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Occupational Health & Safety,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Social Reporting,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Talent Attraction & Retention,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,S&P Global ESG Score,S&P Global ESG Score,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Chemical Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate Strategy - CDP Alignment,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Climate-Related Management Incentives,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Coverage of Environmental Management Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,EMS: Certification/ Audit/ Verification,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,EP - Biological Oxygen Demand,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Energy Consumption,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Reporting - Quantitative Data,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Financial Opportunities Arising from Climate Change,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),34,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Volatile Organic Compounds Emissions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Anti-Competitive Practices,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Average Tenure,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Gender Diversity,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Industry Experience,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Board Type,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,CEO-to-Employee Pay Ratio,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Compliance to Regulatory Standards,93,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Contributions & Other Spending,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corruption & Bribery Cases,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Critical Supplier Identification,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,ESG Integration in SCM Strategy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Family Ownership,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Largest Contributions & Expenditures,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Management Ownership,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Material Issues for Enterprise Value Creation,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Product Innovations (Healthcare),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Product Recalls (Health Care),59,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Development Stages,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Ideation or Applied Research,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Launch,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Risk Culture,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supplier Risk Management Measures,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Supply Chain Transparency & Reporting,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Access to Medicine Strategy Reporting,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Support Programs,93,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Employee Turnover Rate,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Freedom of Association,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Assessment,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Human Rights Mitigation & Remediation,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Patent Filing Policy,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Philanthropic Contributions,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Coverage,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Social Reporting - Quantitative Data,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Trend of Employee Wellbeing,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Question,Workforce Breakdown: Gender,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Economic Governance Dimension,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Environmental Dimension,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Dimension,Social Dimension,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Climate Strategy,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Environmental Policy & Management Systems,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Environmental Reporting,94,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Operational Eco-Efficiency,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Business Ethics,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Corporate Governance,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Innovation Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Materiality,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Policy Influence,91,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Product Quality & Recall Management,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Risk & Crisis Management,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Supply Chain Management,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Access to Healthcare,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Corporate Citizenship & Philanthropy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Human Capital Development,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Human Rights,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Labor Practice Indicators,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Occupational Health & Safety,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Social Reporting,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2018-09-13,Criteria,Talent Attraction & Retention,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,EMS: Certification/ Audit/ Verification,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Reporting - Quantitative Data,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Financial Opportunities Arising from Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),90,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Anti-Competitive Practices,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Average Tenure,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Industry Experience,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO-to-Employee Pay Ratio,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Compliance to Regulatory Standards,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Contributions & Other Spending,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corruption & Bribery Cases,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Critical Supplier Identification,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,ESG Integration in SCM Strategy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Effective Tax Rate,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Ethical Marketing - Complaints Tracking,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Ethical Marketing Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Largest Contributions & Expenditures,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Management Ownership,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Material Issues for Enterprise Value Creation,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Product Innovations (Healthcare),38,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Product Recalls (Health Care),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Development Stages,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Ideation or Applied Research,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Launch,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Risk Culture,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Access to Medicine Strategy Reporting,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Support Programs,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Turnover Rate,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Freedom of Association,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Gender Pay Indicators,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Capital Return on Investment,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Assessment,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Mitigation & Remediation,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Patent Filing Policy,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Philanthropic Contributions,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Quantitative Data,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Trend of Employee Wellbeing,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Workforce Breakdown: Gender,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Economic Governance Dimension,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Environmental Dimension,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Social Dimension,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Climate Strategy,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Environmental Policy & Management Systems,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Environmental Reporting,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Operational Eco-Efficiency,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Business Ethics,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Corporate Governance,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Innovation Management,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Marketing Practices,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Materiality,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Policy Influence,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Product Quality & Recall Management,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Risk & Crisis Management,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Supply Chain Management,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Tax Strategy,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Access to Healthcare,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Human Capital Development,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Human Rights,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Labor Practice Indicators,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Occupational Health & Safety,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Talent Attraction & Retention,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,S&P Global ESG Score,S&P Global ESG Score,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,EMS: Certification/ Audit/ Verification,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Reporting - Quantitative Data,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Environmental Violations,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Financial Opportunities Arising from Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Hazardous Waste,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),90,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Anti-Competitive Practices,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Average Tenure,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Effectiveness,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Gender Diversity,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Industry Experience,83,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Board Type,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,CEO-to-Employee Pay Ratio,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct: Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Codes of Conduct: Systems/ Procedures,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Compliance to Regulatory Standards,89,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Contributions & Other Spending,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corruption & Bribery Cases,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Critical Supplier Identification,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Direct-to-Consumer Marketing,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,ESG Integration in SCM Strategy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Effective Tax Rate,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Ethical Marketing Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Largest Contributions & Expenditures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Management Ownership,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Material Issues for Enterprise Value Creation,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Materiality Analysis,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Open Innovation,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Process Innovations,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Product Innovations (Healthcare),38,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Product Recalls (Health Care),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Core or Basic Research,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Development Stages,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Ideation or Applied Research,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Launch,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Risk Culture,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Risk Governance,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Sensitivity Analysis & Stress Testing (including Water an,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Access to Medicine Strategy Reporting,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Accessibility & Transparency of Outcome Data,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Contribution to Increasing Healthcare Efficiency,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Corporate Citizenship Strategy,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Development Programs,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Support Programs,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Employee Turnover Rate,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Fair Pricing,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Fatalities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,HTA Support of Value Proposition,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Assessment,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Due Diligence Process,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Human Rights Mitigation & Remediation,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Local Capacity Building,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Long-Term Incentives for Employees,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Measure Contribution to Health Outcome,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Patent Filing Policy,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Philanthropic Contributions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Social Reporting - Quantitative Data,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Trend of Employee Wellbeing,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Type of Performance Appraisal,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Type of Philanthropic Activities,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Question,Workforce Breakdown: Gender,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Economic Governance Dimension,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Environmental Dimension,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Dimension,Social Dimension,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Climate Strategy,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Environmental Policy & Management Systems,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Environmental Reporting,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Operational Eco-Efficiency,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Business Ethics,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Corporate Governance,73,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Innovation Management,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Marketing Practices,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Materiality,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Policy Influence,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Product Quality & Recall Management,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Risk & Crisis Management,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Supply Chain Management,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Tax Strategy,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Access to Healthcare,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Addressing Cost Burden,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Corporate Citizenship & Philanthropy,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Health Outcome Contribution,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Human Capital Development,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Human Rights,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Labor Practice Indicators,7,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Occupational Health & Safety,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2019-09-13,Criteria,Talent Attraction & Retention,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Energy Consumption,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Environmental Violations,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),90,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Waste Disposal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Anti-Competitive Practices,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Average Tenure,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Gender Diversity,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Type,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO-to-Employee Pay Ratio,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Compliance to Regulatory Standards,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corruption & Bribery Cases,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Critical Supplier Identification,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,ESG Integration in SCM Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Ethical Marketing - Complaints Tracking,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Breaches,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Governance,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Largest Contributions & Expenditures,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Material Issues for Enterprise Value Creation,37,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Process Innovations,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Product Recalls (Health Care),21,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,R&D breakout by Innovation Phase,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Risk Culture,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Risk Governance,24,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supply Chain Risk Exposure,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supply Chain Transparency & Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Access to Medicine Strategy Reporting,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corporate Citizenship Strategy,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Development Programs,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Support Programs,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Turnover Rate,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Fair Pricing,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Freedom of Association,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Gender Pay Indicators,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,HTA Support of Value Proposition,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Capital Return on Investment,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Assessment,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Due Diligence Process,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Long-Term Incentives for Employees,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Patent Filing Policy,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Philanthropic Contributions,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Social Reporting - Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Training & Development Inputs,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Type of Performance Appraisal,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Type of Philanthropic Activities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Workforce Breakdown: Gender,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Economic Governance Dimension,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Environmental Dimension,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Social Dimension,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Climate Strategy,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Environmental Policy & Management Systems,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Operational Eco-Efficiency,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Business Ethics,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Innovation Management,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Marketing Practices,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Materiality,26,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Policy Influence,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Product Quality & Recall Management,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Risk & Crisis Management,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Supply Chain Management,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Access to Healthcare,69,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Addressing Cost Burden,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Human Capital Development,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Human Rights,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Labor Practice Indicators,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Occupational Health & Safety,8,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Social Reporting,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Talent Attraction & Retention,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,S&P Global ESG Score,S&P Global ESG Score,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Energy Consumption,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Environmental Violations,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Financial Risks of Climate Change,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Hazardous Waste,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Indirect Greenhouse Gas Emissions (Scope 3),90,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Sustainability Reporting Assurance,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Waste Disposal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Anti-Competitive Practices,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Average Tenure,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Gender Diversity,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Board Type,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,CEO-to-Employee Pay Ratio,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Compliance to Regulatory Standards,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corruption & Bribery Cases,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Critical Supplier Identification,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,ESG Integration in SCM Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,IT Security/ Cybersecurity Process & Infrastructure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Largest Contributions & Expenditures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Material Issues for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Process Innovations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Product Recalls (Health Care),21,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,R&D breakout by Innovation Phase,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Risk Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Sensitivity Analysis & Stress Testing (including Water an,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supply Chain Risk Exposure,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Supply Chain Transparency & Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Access to Medicine Strategy Reporting,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Contribution to Increasing Healthcare Efficiency,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Corporate Citizenship Strategy,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Development Programs,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Support Programs,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Employee Turnover Rate,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Fair Pricing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,HTA Support of Value Proposition,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Due Diligence Process,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Long-Term Incentives for Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Occupational Illness Frequency Rate (OIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Philanthropic Contributions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Return on Employee Development Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Social Reporting - Coverage,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Type of Performance Appraisal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Type of Philanthropic Activities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Question,Workforce Breakdown: Gender,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Economic Governance Dimension,37,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Environmental Dimension,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Dimension,Social Dimension,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Climate Strategy,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Environmental Policy & Management Systems,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Environmental Reporting,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Operational Eco-Efficiency,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Business Ethics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Information Security/ Cybersecurity & System Availability,12,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Innovation Management,6,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Materiality,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Policy Influence,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Product Quality & Recall Management,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Risk & Crisis Management,7,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Supply Chain Management,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Access to Healthcare,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Addressing Cost Burden,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Corporate Citizenship & Philanthropy,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Human Capital Development,12,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Human Rights,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Labor Practice Indicators,4,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Occupational Health & Safety,8,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Social Reporting,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2020-11-13,Criteria,Talent Attraction & Retention,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,S&P Global ESG Score,S&P Global ESG Score,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate Risk Assessment - Transition Risks,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate-Related Scenario Analysis,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Environmental Violations,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Hazardous Waste,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Physical Climate Risk Adaptation,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Sustainability Reporting Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Water Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Anti-Competitive Practices,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Average Tenure,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Gender Diversity,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Type,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO-to-Employee Pay Ratio,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Compliance to Regulatory Standards,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corruption & Bribery Cases,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Critical Supplier Identification,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,ESG Integration in SCM Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Effective Tax Rate,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Ethical Marketing - Complaints Tracking,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Breaches,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Governance,18,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Process & Infrastructure,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Largest Contributions & Expenditures,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Material Issues for Enterprise Value Creation,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Process Innovations,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Product Recalls (Health Care),31,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,R&D breakout by Innovation Phase,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Risk Culture,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Risk Governance,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Sensitivity Analysis & Stress Testing (including Water an,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Access to Medicine Strategy Reporting,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Contribution to Increasing Healthcare Efficiency,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corporate Citizenship Strategy,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Discrimination & Harassment,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Development Programs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Support Programs,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Turnover Rate,9,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Fair Pricing,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Gender Pay Indicators,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,HTA Support of Value Proposition,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Hiring,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Capital Return on Investment,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Assessment,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Commitment,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Due Diligence Process,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Long-Term Incentives for Employees,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Patent Filing Policy,71,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,People Analytics,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Philanthropic Contributions,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Strategic Workforce Planning,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Training & Development Inputs,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Type of Performance Appraisal,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Type of Philanthropic Activities,79,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Gender,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Other Minorities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Economic Governance Dimension,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Environmental Dimension,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Social Dimension,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Climate Strategy,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Environmental Policy & Management Systems,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Environmental Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Operational Eco-Efficiency,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Business Ethics,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Information Security/ Cybersecurity & System Availability,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Innovation Management,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Marketing Practices,65,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Materiality,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Policy Influence,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Product Quality & Recall Management,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Risk & Crisis Management,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Supply Chain Management,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Tax Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Access to Healthcare,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Addressing Cost Burden,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Corporate Citizenship & Philanthropy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Human Capital Development,26,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Human Rights,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Labor Practice Indicators,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Occupational Health & Safety,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Talent Attraction & Retention,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,S&P Global ESG Score,S&P Global ESG Score,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate Risk Assessment - Transition Risks,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Climate-Related Scenario Analysis,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Environmental Violations,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Hazardous Waste,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Physical Climate Risk Adaptation,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Sustainability Reporting Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Water Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Anti-Competitive Practices,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Average Tenure,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Gender Diversity,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Board Type,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,CEO-to-Employee Pay Ratio,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Compliance to Regulatory Standards,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corruption & Bribery Cases,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Critical Supplier Identification,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,ESG Integration in SCM Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Effective Tax Rate,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,IT Security/ Cybersecurity Process & Infrastructure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Largest Contributions & Expenditures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Material Issues for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Process Innovations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Product Recalls (Health Care),31,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,R&D breakout by Innovation Phase,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Risk Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Sensitivity Analysis & Stress Testing (including Water an,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Access to Medicine Strategy Reporting,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Contribution to Increasing Healthcare Efficiency,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Corporate Citizenship Strategy,68,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Discrimination & Harassment,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Development Programs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Support Programs,85,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Employee Turnover Rate,9,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Fair Pricing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,HTA Support of Value Proposition,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Hiring,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Commitment,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Due Diligence Process,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Long-Term Incentives for Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Patent Filing Policy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,People Analytics,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Philanthropic Contributions,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Strategic Workforce Planning,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Type of Performance Appraisal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Type of Philanthropic Activities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Gender,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Other Minorities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Economic Governance Dimension,37,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Environmental Dimension,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Dimension,Social Dimension,26,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Climate Strategy,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Environmental Policy & Management Systems,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Environmental Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Operational Eco-Efficiency,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Business Ethics,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Information Security/ Cybersecurity & System Availability,12,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Innovation Management,6,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Materiality,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Policy Influence,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Product Quality & Recall Management,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Risk & Crisis Management,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Supply Chain Management,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Tax Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Access to Healthcare,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Addressing Cost Burden,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Corporate Citizenship & Philanthropy,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Human Capital Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Human Rights,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Labor Practice Indicators,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Occupational Health & Safety,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2021-12-16,Criteria,Talent Attraction & Retention,2,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Biodiversity Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate Risk Assessment - Transition Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate-Related Scenario Analysis,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Policy & Commitments,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Violations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Hazardous Waste,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Net-Zero Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,No Deforestation Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Physical Climate Risk Adaptation,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Sustainability Reporting Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Water Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Anti-Competitive Practices,58,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Average Tenure,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Gender Diversity,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Type,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO-to-Employee Pay Ratio,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Compliance to Regulatory Standards,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corruption & Bribery Cases,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Critical Supplier Identification,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,ESG Integration in SCM Strategy,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Effective Tax Rate,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Breaches,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Governance,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,23,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Largest Contributions & Expenditures,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Material Issues for Enterprise Value Creation,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Process Innovations,49,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Product Recalls (Health Care),69,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,R&D breakout by Innovation Phase,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Risk Culture,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Risk Governance,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supplier Risk Management Measures,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,UN Global Compact Membership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corporate Citizenship Strategy,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Direct-to-Consumer Marketing,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Discrimination & Harassment,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Development Programs,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Support Programs,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Turnover Rate,24,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Ethical Marketing - Complaints Tracking,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Fair Pricing,59,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Fatalities,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Gender Pay Indicators,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,HTA Support of Value Proposition,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Hiring,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Capital Return on Investment,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Assessment,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Commitment,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Due Diligence Process,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Impact on Access to Healthcare,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Local Capacity Building,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Long-Term Incentives for Employees,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,OHS Policy,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,OHS Programs,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Patent Filing Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,People Analytics,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Philanthropic Contributions,26,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Strategic Workforce Planning,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Training & Development Inputs,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Trend of Employee Wellbeing,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Type of Performance Appraisal,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Type of Philanthropic Activities,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Gender,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Other Minorities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,91,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Economic Governance Dimension,54,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Environmental Dimension,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Social Dimension,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Biodiversity,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Climate Strategy,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Environmental Policy & Management Systems,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Environmental Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Operational Eco-Efficiency,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Business Ethics,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Innovation Management,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Materiality,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Policy Influence,52,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Product Quality & Recall Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Risk & Crisis Management,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Supply Chain Management,39,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Tax Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Access to Healthcare,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Addressing Cost Burden,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Human Capital Development,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Human Rights,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Labor Practice Indicators,53,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Marketing Practices,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Occupational Health & Safety,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Talent Attraction & Retention,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,S&P Global ESG Score,S&P Global ESG Score,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Biodiversity Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate Risk Assessment - Transition Risks,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate Risk Management,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate-Related Management Incentives,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Climate-Related Scenario Analysis,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Direct Greenhouse Gas Emissions (Scope 1),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,EMS: Certification/ Audit/ Verification,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Emissions Reduction Targets,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Energy Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Policy & Commitments,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Environmental Violations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Financial Risks of Climate Change,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Hazardous Waste,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 2),70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Indirect Greenhouse Gas Emissions (Scope 3),100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Net-Zero Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,No Deforestation Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Physical Climate Risk Adaptation,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Sustainability Reporting Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Waste Disposal,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Water Consumption,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Anti-Competitive Practices,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Average Tenure,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Gender Diversity,88,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Board Type,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,CEO-to-Employee Pay Ratio,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct: Coverage,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Compliance to Regulatory Standards,95,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Contributions & Other Spending,67,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corruption & Bribery Cases,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Critical Supplier Identification,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Dual Class Shares,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,ESG Integration in SCM Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Effective Tax Rate,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Governance,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,IT Security/ Cybersecurity Process & Infrastructure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Largest Contributions & Expenditures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Management Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Material Issues for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Materiality Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Process Innovations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Product Recalls (Health Care),69,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,R&D breakout by Innovation Phase,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Risk Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Sensitivity Analysis & Stress Testing (including Water an,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supplier Code of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supplier Risk Management Measures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supply Chain Risk Exposure,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Supply Chain Transparency & Reporting,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,UN Global Compact Membership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Access to Healthcare Programs (Products & Drugs),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Contribution to Increasing Healthcare Efficiency,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Corporate Citizenship Strategy,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Discrimination & Harassment,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Development Programs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Support Programs,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Employee Turnover Rate,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Fair Pricing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,HTA Support of Value Proposition,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Hiring,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Commitment,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Due Diligence Process,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Impact on Access to Healthcare,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Local Capacity Building,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Long-Term Incentives for Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,90,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,OHS Policy,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,OHS Programs,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Patent Filing Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,People Analytics,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Philanthropic Contributions,26,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Social Reporting - Assurance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Social Reporting - Coverage,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Strategic Workforce Planning,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Type of Performance Appraisal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Type of Philanthropic Activities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Gender,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Other Minorities,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,91,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Economic Governance Dimension,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Environmental Dimension,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Dimension,Social Dimension,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Biodiversity,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Climate Strategy,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Environmental Policy & Management Systems,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Environmental Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Operational Eco-Efficiency,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Business Ethics,51,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Corporate Governance,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Information Security/ Cybersecurity & System Availability,23,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Innovation Management,6,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Materiality,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Policy Influence,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Product Quality & Recall Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Risk & Crisis Management,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Supply Chain Management,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Tax Strategy,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Access to Healthcare,45,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Addressing Cost Burden,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Corporate Citizenship & Philanthropy,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Human Capital Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Human Rights,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Labor Practice Indicators,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Occupational Health & Safety,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Social Reporting,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2022-11-18,Criteria,Talent Attraction & Retention,11,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Biodiversity Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Biodiversity Risk Assessment,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate Governance,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate Risk Management,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate-Related Management Incentives,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate-Related Scenario Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,EMS: Certification/ Audit/ Verification,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Emissions Reduction Targets,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Energy Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Environmental Policy & Commitments,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Environmental Violations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Exposure to Hazardous Substances,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Financial Risks of Climate Change,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Hazardous Waste,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),94,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Life Cycle Assessment,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Net-Zero Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,No Deforestation Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Physical Climate Risk Adaptation,24,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Design Criteria,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Waste Disposal,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Average Tenure,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Gender Diversity,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Independence,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Type,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO-to-Employee Pay Ratio,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Compliance to Regulatory Standards,96,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Contributions & Other Spending,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Governance,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,KPIs for Supplier Assessment and Development,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,KPIs for Supplier Screening,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Largest Contributions & Expenditures,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Management Ownership,97,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Material Issues for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Material Issues for External Stakeholders,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Analysis,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Metrics for External Stakeholders,22,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Process Innovations,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Recalls (Health Care),68,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,R&D breakout by Innovation Phase,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Culture,43,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Management Processes,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Assessment and Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Code of Conduct,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier ESG Program,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Screening,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Reporting Assurance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Reporting Boundaries,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Taxonomies,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,UN Global Compact Membership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,62,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Direct-to-Consumer Marketing,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Discrimination & Harassment,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Development Programs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Support Programs,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Turnover Rate,24,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Ethical Marketing - Complaints Tracking,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Fair Pricing,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Fatalities,28,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Gender Pay Indicators,23,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,HTA Support of Value Proposition,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Hiring,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Assessment,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Commitment,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Due Diligence Process,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Impact on Access to Healthcare,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Long-Term Incentives for Employees,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,29,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,OHS Policy,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,OHS Programs,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Patent Filing Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Training & Development Inputs,39,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Trend of Employee Wellbeing,17,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Type of Performance Appraisal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Workforce Breakdown: Gender,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Economic Governance Dimension,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Environmental Dimension,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Social Dimension,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Biodiversity,6,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Climate Strategy,32,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Environmental Policy & Management Systems,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Product Stewardship,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Business Ethics,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Corporate Governance,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Innovation Management,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Materiality,11,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Policy Influence,25,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Product Quality & Recall Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Risk & Crisis Management,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Supply Chain Management,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Access to Healthcare,63,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Addressing Cost Burden,55,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Human Capital Development,14,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Human Rights,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Labor Practice Indicators,46,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Marketing Practices,72,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Occupational Health & Safety,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Talent Attraction & Retention,31,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,S&P Global ESG Score,S&P Global ESG Score,34,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Biodiversity Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Biodiversity Risk Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate Governance,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate Risk Management,57,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate-Related Management Incentives,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Climate-Related Scenario Analysis,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Coverage of Environmental Management Policy,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Direct Greenhouse Gas Emissions (Scope 1),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,EMS: Certification/ Audit/ Verification,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Emissions Reduction Targets,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Energy Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Environmental Policy & Commitments,74,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Environmental Violations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Exposure to Hazardous Substances,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Financial Opportunities Arising from Climate Change,70,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Financial Risks of Climate Change,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Hazardous Waste,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 2),80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Indirect Greenhouse Gas Emissions (Scope 3),94,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Life Cycle Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Net-Zero Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,No Deforestation Commitment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Physical Climate Risk Adaptation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Design Criteria,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,TCFD Disclosure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Waste Disposal,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Water Consumption,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Average Tenure,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Diversity Policy,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Effectiveness,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Gender Diversity,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Independence,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Industry Experience,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Board Type,77,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO Compensation - Long-Term Performance Alignment,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO Compensation - Success Metrics,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,CEO-to-Employee Pay Ratio,81,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Codes of Conduct,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Codes of Conduct: Systems/ Procedures,56,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Compliance to Regulatory Standards,96,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Contributions & Other Spending,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Corruption & Bribery,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Effective Tax Rate,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Emerging Risks,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Family Ownership,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Government Ownership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Governance,38,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Measures,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,IT Security/ Cybersecurity Process & Infrastructure,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,KPIs for Supplier Assessment and Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,KPIs for Supplier Screening,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Largest Contributions & Expenditures,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lobbying and Trade Associations - Climate Alignment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Management Ownership,97,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Management Ownership Requirements,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Material Issues for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Material Issues for External Stakeholders,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Analysis,15,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Metrics for Enterprise Value Creation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Materiality Metrics for External Stakeholders,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Non-Executive Chairperson/ Lead Director,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Open Innovation,27,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Process Innovations,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Innovations (Healthcare),8,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Product Recalls (Health Care),68,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,R&D Spending,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,R&D breakout by Innovation Phase,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Reporting on breaches,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Culture,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Risk Management Processes,10,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Assessment and Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Code of Conduct,75,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier ESG Program,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Supplier Screening,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Reporting Assurance,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Reporting Boundaries,20,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Sustainability Taxonomies,,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Tax Reporting,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Tax Strategy and Governance,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,UN Global Compact Membership,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Access to Healthcare Programs (Products & Drugs),40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Accessibility & Transparency of Outcome Data,76,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Contribution to Increasing Healthcare Efficiency,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Direct-to-Consumer Marketing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Discrimination & Harassment,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Development Programs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Support Programs,36,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Employee Turnover Rate,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Ethical Marketing - Complaints Tracking,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Ethical Marketing Commitment,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Fair Pricing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Fatalities,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Freedom of Association,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Gender Pay Indicators,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,HTA Support of Value Proposition,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Hiring,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Capital Return on Investment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Assessment,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Commitment,84,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Due Diligence Process,35,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Human Rights Mitigation & Remediation,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Impact on Access to Healthcare,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Local Capacity Building,80,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Long-Term Incentives for Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Contractors,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Lost-Time Injury Frequency Rate (LTIFR) - Employees,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Measure Contribution to Health Outcome,19,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,OHS Policy,66,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,OHS Programs,64,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Patent Filing Policy,60,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Training & Development Inputs,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Trend of Employee Wellbeing,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Type of Performance Appraisal,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Workforce Breakdown: Gender,50,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Question,Workforce Breakdown: Race/ Ethnicity & Nationality,100,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Economic Governance Dimension,41,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Environmental Dimension,44,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Dimension,Social Dimension,24,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Biodiversity,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Climate Strategy,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Environmental Policy & Management Systems,42,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Product Stewardship,8,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Business Ethics,61,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Corporate Governance,78,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Information Security/ Cybersecurity & System Availability,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Innovation Management,6,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Materiality,3,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Policy Influence,16,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Product Quality & Recall Management,82,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Risk & Crisis Management,3,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Supply Chain Management,7,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Tax Strategy,21,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Access to Healthcare,48,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Addressing Cost Burden,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Health Outcome Contribution,47,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Human Capital Development,0,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Human Rights,30,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Labor Practice Indicators,40,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Marketing Practices,33,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Occupational Health & Safety,23,002403,BMY,Bristol-Myers Squibb Company
4623856,2023-10-27,Criteria,Talent Attraction & Retention,7,002403,BMY,Bristol-Myers Squibb Company
